BR100 Decreased By (-0.32%)
BR30 Decreased By (-0.71%)
KSE100 Decreased By (-0.29%)
KSE30 Decreased By (-0.55%)
BECO 5.84 Decreased By ▼ -0.19 (-3.15%)
BML 58.00 Increased By ▲ 5.25 (9.95%)
BOP 33.79 Decreased By ▼ -0.46 (-1.34%)
CNERGY 8.15 Decreased By ▼ -0.01 (-0.12%)
DCL 11.80 Decreased By ▼ -0.54 (-4.38%)
FCCL 53.50 Decreased By ▼ -0.39 (-0.72%)
FCSC 5.45 Increased By ▲ 0.23 (4.41%)
FFL 17.87 Decreased By ▼ -0.16 (-0.89%)
FNEL 1.31 Increased By ▲ 0.01 (0.77%)
HUMNL 11.13 Increased By ▲ 0.13 (1.18%)
KEL 8.04 Decreased By ▼ -0.07 (-0.86%)
KOSM 5.45 Increased By ▲ 0.07 (1.3%)
MLCF 87.35 Decreased By ▼ -0.70 (-0.8%)
NBP 184.40 Decreased By ▼ -2.08 (-1.12%)
PACE 11.58 Increased By ▲ 0.86 (8.02%)
PAEL 40.24 Increased By ▲ 0.30 (0.75%)
PIAHCLA 26.16 Decreased By ▼ -0.01 (-0.04%)
PIBTL 17.13 Decreased By ▼ -0.19 (-1.1%)
PPL 228.75 Decreased By ▼ -4.03 (-1.73%)
PRL 34.50 Decreased By ▼ -0.45 (-1.29%)
PTC 67.42 Decreased By ▼ -0.14 (-0.21%)
SEARL 90.95 Increased By ▲ 0.02 (0.02%)
SSGC 26.84 Decreased By ▼ -0.33 (-1.21%)
TELE 8.54 Decreased By ▼ -0.03 (-0.35%)
THCCL 66.14 Increased By ▲ 6.01 (10%)
TPLP 9.33 Increased By ▲ 0.57 (6.51%)
TREET 24.43 Decreased By ▼ -0.11 (-0.45%)
TRG 71.71 Decreased By ▼ -0.04 (-0.06%)
WAVES 10.98 Increased By ▲ 1.00 (10.02%)
WTL 1.28 Increased By ▲ 0.02 (1.59%)
Markets

Britain's FTSE supported by financials, AstraZeneca

MILAN: UK shares rose on Thursday as financials rallied, tracking strength in their European peers and heavyweight d
Published November 8, 2018 Updated November 8, 2018 11:30am

MILAN: UK shares rose on Thursday as financials rallied, tracking strength in their European peers and heavyweight drugmaker AstraZeneca was lifted by a strong update.

The FTSE 100 rose 0.3 percent by 0955 GMT, as relief about the U.S. midterm vote delivering no big surprises continued, while the domestically focused mid-cap index rose 0.3 percent.

"With the Dow Jones posting some big gains on Wednesday, the post-US midterm growth rolled over into Thursday," said Connor Campbell, analyst at Spreadex in London.

AstraZeneca rose 2 percent after strong demand for its new drugs -- especially those for cancer -- drove a return to sales growth in the third quarter and the drugmaker said it now anticipated years of sustained improvement.

"This was a decent set of results with the reiteration of guidance largely expected. That said the continued outperformance from the new product launches and core diabetes portfolio should be well received," said Liberum analyst Graham Doyle.

In the same sector, which is seen benefiting from the U.S. vote's outcome, Hikma rallied 6.8 percent after it raised full-year revenue expectations for its key injectables division, as it supplies more opioid painkillers amid a shortage in the United States.

Analysts say a split Congress that is unlikely to significantly cut government healthcare programmes or reduce drug prices in the world's biggest and most profitable market.

Coca-Cola HBC rose 5 percent to the top of the FTSE 100 after the soft drink bottler reported slightly higher-than-expected quarterly revenue growth, driven by higher volumes.

Inmarsat however fell 6.6 percent after trimming its full-year revenues guidance to the lower end of its previous target.

Among other companies reporting results was Britain's No. 2 supermarket Sainsbury, which is seeking is seeking regulatory approval to take over rival Asda.

Its shares rose as much as 1.8 percent after cost savings helped it beat forecasts with a 20 percent increase in first-half profit. They later pared gains and were down 0.5 percent.

Jefferies said the update was largely uneventful and that developments relating to the 7.4 billion-pound Asda takeover were key.

"We believe the market efficiently prices in the possibility of the deal being blocked and that of an approval being granted with fairly extensive store disposal requirements," they said.

Financials provided the biggest boost to the FTSE, with shares in Lloyds, HSBC and Royal Bank of Scotland all rising more than 1 percent as the broader European banking sector rose on the back of strong results.

Among top fallers was Marks & Spencer after HSBC cut its price target on the stock.

Copyright Reuters, 2018
 

Comments

Comments are closed for this article.